ENTERO HEALTHCARE SOLU L (ENTERO)

NSE: ₹1,139.50
BSE: ₹1,140.50
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 76.59 106.56 122.38 112.83 101.15 72.30 79.35 83.22 106.74 78.93
YOY Revenue Growth % - - - - 32.08% -32.15% -35.16% -26.24% 5.52% 9.17%
Other Income 16.25 42.40 32.17 28.81 27.51 25.87 26.29 24.23 23.25 39.96
Total Income 92.84 148.96 154.56 141.65 128.66 98.18 105.64 107.45 129.99 118.89
Total Expenses + 92.14 123.09 126.81 121.43 114.19 86.01 96.48 99.84 124.12 106.85
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 14.95 12.99 11.49 12.95 12.04 10.87 13.98 14.33 15.13 14.43
Other Expenses 7.24 9.06 8.20 6.64 8.79 5.83 8.99 10.70 7.49 12.19
Operating Profit -15.55 -16.53 -4.43 -8.60 -13.04 -13.70 -17.12 -16.62 -17.38 -27.92
OPM % -20.3% -15.5% -3.6% -7.6% -12.9% -19% -21.6% -20% -16.3% -35.4%
Profit Before Tax + 0.70 25.87 27.74 20.22 14.47 -34.91 9.16 7.61 1.37 12.04
Tax Expense -0.25 -11.41 6.87 4.89 3.69 -7.85 2.21 1.91 0.57 -1.38
Tax % -35.7% -44.1% 24.8% 24.2% 25.5% - 24.1% 25.1% 41.4% -11.4%
Profit After Tax 0.95 37.28 20.88 15.33 10.78 -27.07 6.96 5.70 0.81 13.42
EPS (Basic) 0.27 10.19 4.80 3.52 2.48 -6.39 1.60 1.31 0.18 3.08

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024
Revenue from Operations 348.24 408.67 318.16
YOY Revenue Growth % -14.79% 28.45% -
Other Income 113.72 114.37 89.92
Total Income 461.96 523.04 408.09
Total Expenses + 427.28 449.18 383.72
Employee Benefit Expense 57.87 47.35 56.25
Other Expenses 39.37 29.45 26.87
Operating Profit -79.04 -40.51 -65.56
OPM % -22.7% -9.9% -20.6%
Profit Before Exceptional 34.68 73.86 24.36
Exceptional Items -4.50 -47.08 0.00
Profit Before Tax + 30.19 26.78 24.36
Tax Expense 3.31 7.60 -14.08
Tax % 11% 28.4% -57.8%
Profit After Tax 26.88 19.18 38.44
EPS (Basic) 6.18 4.41 10.63

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 1,428.76 994.07 107.60
Property, Plant & Equipment 17.92 25.34 31.06
Capital Work in Progress 0.00 0.00 0.00
Non-Current Investments 0.00 251.62 0.00
Goodwill 0.00 0.00 0.00
Other Intangible Assets 8.11 2.95 3.38
Current Assets + 728.90 809.46 1,660.99
Inventories 73.33 108.98 47.81
Trade Receivables 103.47 99.86 113.19
Cash and Cash Equivalents 56.76 151.18 93.34
Current Investments 59.60 25.76 0.00
LIABILITIES & EQUITY
Total Equity 1,683.04 1,650.38 1,626.41
Equity Share Capital 43.51 43.51 43.49
Other Equity 1,639.53 1,606.87 1,582.92
Non-Current Liabilities 152.75 23.22 14.35
Current Liabilities 321.87 129.93 127.82
Total Liabilities 474.63 153.15 142.17

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024
Cash from Operating Activities -59.72 -109.02 -75.65
Cash from Investing Activities -132.28 207.75 -762.69
Cash from Financing Activities 97.58 -40.89 925.56
Net Increase/Decrease in Cash -94.42 57.84 87.22